113 related articles for article (PubMed ID: 17026997)
1. In situ detection of global DNA hypomethylation in exfoliative urine cytology of patients with suspected bladder cancer.
Seifert HH; Schmiemann V; Mueller M; Kazimirek M; Onofre F; Neuhausen A; Florl AR; Ackermann R; Boecking A; Schulz WA; Grote HJ
Exp Mol Pathol; 2007 Jun; 82(3):292-7. PubMed ID: 17026997
[TBL] [Abstract][Full Text] [Related]
2. Aberrant methylation of RARbeta2 and APC genes in voided urine as molecular markers for early detection of bilharzial and nonbilharzial bladder cancer.
Eissa S; Swellam M; El-Khouly IM; Kassim SK; Shehata H; Mansour A; Esmat M; Nossier AI; Hamdy MA; Awad NM; El-Ahmady O
Cancer Epidemiol Biomarkers Prev; 2011 Aug; 20(8):1657-64. PubMed ID: 21680534
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma.
Moussa M; Omran Z; Nosseir M; Lotfy A; Swellam T
APMIS; 2009 Jan; 117(1):45-52. PubMed ID: 19161536
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation and expression of LINE-1 and HERV-K provirus sequences in urothelial and renal cell carcinomas.
Florl AR; Löwer R; Schmitz-Dräger BJ; Schulz WA
Br J Cancer; 1999 Jul; 80(9):1312-21. PubMed ID: 10424731
[TBL] [Abstract][Full Text] [Related]
5. DNA demethylation is directly related to tumour progression: evidence in normal, pre-malignant and malignant cells from uterine cervix samples.
de Capoa A; Musolino A; Della Rosa S; Caiafa P; Mariani L; Del Nonno F; Vocaturo A; Donnorso RP; Niveleau A; Grappelli C
Oncol Rep; 2003; 10(3):545-9. PubMed ID: 12684621
[TBL] [Abstract][Full Text] [Related]
6. A novel set of DNA methylation markers in urine sediments for sensitive/specific detection of bladder cancer.
Yu J; Zhu T; Wang Z; Zhang H; Qian Z; Xu H; Gao B; Wang W; Gu L; Meng J; Wang J; Feng X; Li Y; Yao X; Zhu J
Clin Cancer Res; 2007 Dec; 13(24):7296-304. PubMed ID: 18094410
[TBL] [Abstract][Full Text] [Related]
7. Combined morphologic and fluorescence in situ hybridization analysis of voided urine samples for the detection and follow-up of bladder cancer in patients with benign urine cytology.
Daniely M; Rona R; Kaplan T; Olsfanger S; Elboim L; Freiberger A; Lew S; Leibovitch I
Cancer; 2007 Dec; 111(6):517-24. PubMed ID: 17963263
[TBL] [Abstract][Full Text] [Related]
8. Utility of a multiprobe fluorescence in situ hybridization assay in the detection of superficial urothelial bladder cancer.
Marín-Aguilera M; Mengual L; Ribal MJ; Burset M; Arce Y; Ars E; Oliver A; Villavicencio H; Algaba F; Alcaraz A
Cancer Genet Cytogenet; 2007 Mar; 173(2):131-5. PubMed ID: 17321328
[TBL] [Abstract][Full Text] [Related]
9. Altered global methylation of DNA: an epigenetic difference in susceptibility for lung cancer is associated with its progression.
Piyathilake CJ; Frost AR; Bell WC; Oelschlager D; Weiss H; Johanning GL; Niveleau A; Heimburger DC; Grizzle WE
Hum Pathol; 2001 Aug; 32(8):856-62. PubMed ID: 11521231
[TBL] [Abstract][Full Text] [Related]
10. Hypomethylation of L1 LINE sequences prevailing in human urothelial carcinoma.
Jürgens B; Schmitz-Dräger BJ; Schulz WA
Cancer Res; 1996 Dec; 56(24):5698-703. PubMed ID: 8971178
[TBL] [Abstract][Full Text] [Related]
11. Methylational urinalysis: a prospective study of bladder cancer patients and age stratified benign controls.
Yates DR; Rehman I; Meuth M; Cross SS; Hamdy FC; Catto JW
Oncogene; 2006 Mar; 25(13):1984-8. PubMed ID: 16288222
[TBL] [Abstract][Full Text] [Related]
12. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains.
Tamas EF; Epstein JI
Am J Surg Pathol; 2007 Mar; 31(3):390-7. PubMed ID: 17325480
[TBL] [Abstract][Full Text] [Related]
13. [Numerical aberrations of chromosomes 11 and 17 detected by fish--fluorescence in situ hybridization combined with cytology in exfoliated cells from voided urine in patients with urothelial carcinoma of the bladder].
Asali MG; Kaneti J; Manor E
Harefuah; 2007 Dec; 146(12):914-9, 1000. PubMed ID: 18254439
[TBL] [Abstract][Full Text] [Related]
14. The relationship between 8-oxo-7,8-dihydro-2'-deoxyguanosine level and extent of cytosine methylation in leukocytes DNA of healthy subjects and in patients with colon adenomas and carcinomas.
Guz J; Foksinski M; Siomek A; Gackowski D; Rozalski R; Dziaman T; Szpila A; Olinski R
Mutat Res; 2008 Apr; 640(1-2):170-3. PubMed ID: 18281064
[TBL] [Abstract][Full Text] [Related]
15. DNA hypomethylation on pericentromeric satellite regions significantly correlates with loss of heterozygosity on chromosome 9 in urothelial carcinomas.
Nakagawa T; Kanai Y; Ushijima S; Kitamura T; Kakizoe T; Hirohashi S
J Urol; 2005 Jan; 173(1):243-6. PubMed ID: 15592089
[TBL] [Abstract][Full Text] [Related]
16. Reflex UroVysion testing of bladder cancer surveillance patients with equivocal or negative urine cytology: a prospective study with focus on the natural history of anticipatory positive findings.
Yoder BJ; Skacel M; Hedgepeth R; Babineau D; Ulchaker JC; Liou LS; Brainard JA; Biscotti CV; Jones JS; Tubbs RR
Am J Clin Pathol; 2007 Feb; 127(2):295-301. PubMed ID: 17210520
[TBL] [Abstract][Full Text] [Related]
17. Global hypomethylation is common in prostate cancer cells: a quantitative predictor for clinical outcome?
Brothman AR; Swanson G; Maxwell TM; Cui J; Murphy KJ; Herrick J; Speights VO; Isaac J; Rohr LR
Cancer Genet Cytogenet; 2005 Jan; 156(1):31-6. PubMed ID: 15588853
[TBL] [Abstract][Full Text] [Related]
18. [Influence of blood cells in urine samples on results of screening for urothelial carcinoma with NMP22 bladder chek].
Ueda Y; Kawaguchi R; Takiuchi H; Kokura K; Yoshimoto T; Mitsui Y; Suzuki T; Jun Q; Higuchi Y; Maruyama T; Kondoh N; Nozima M; Yamamoto S; Shima H
Hinyokika Kiyo; 2009 Feb; 55(2):71-4. PubMed ID: 19301610
[TBL] [Abstract][Full Text] [Related]
19. The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer.
Streeper NM; Simons CM; Konety BR; Muirhead DM; Williams RD; O'Donnell MA; Joudi FN
BJU Int; 2009 Feb; 103(4):475-9. PubMed ID: 18990174
[TBL] [Abstract][Full Text] [Related]
20. p16ink4 immunoreactivity is a reliable marker for urothelial carcinoma in situ.
Yin M; Bastacky S; Parwani AV; McHale T; Dhir R
Hum Pathol; 2008 Apr; 39(4):527-35. PubMed ID: 18234280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
